Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability
Crossref DOI link: https://doi.org/10.1038/s41598-018-20715-4
Published Online: 2018-02-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Cuihua
Chen, Xiaolong
Huang, Yibing
Chen, Yuxin http://orcid.org/0000-0001-6649-9324
Text and Data Mining valid from 2018-02-02
Version of Record valid from 2018-02-02
Article History
Received: 27 November 2017
Accepted: 22 January 2018
First Online: 2 February 2018
Competing Interests
: The authors declare that they have no competing interests.